Printer Friendly

DURAMED ANNOUNCES ESTROPIPATE INTRODUCTION

 CINCINNATI, Nov. 30 /PRNewswire/ -- E. Thomas Arington, chairman and president of Duramed Pharmaceuticals, Inc. (OTC Bulletin Board: DRMD) announced today that it has entered into an agreement with Ortho Pharmaceutical Corporation under which Duramed has been granted rights to market Estropipate tablets. Product shipments are scheduled to begin the week of Dec. 6, 1993. Arington stated, "This product agreement is consistent with Duramed's strategy of developing opportunities through alliances in the healthcare industry."
 Duramed Pharmaceuticals, Inc. manufactures and sells generic drug products comprised of various dosages of prescription and over-the- counter drugs. The company's stock is traded on the OTC Bulletin Board under the symbol DRMD.
 -0- 11/30/93 R
 /CONTACT: E. Thomas Arington, chairman and chief executive officer, or Timothy J. Holt, vice president-finance, of Duramed Pharmaceuticals, Inc., 513-731-9900/
 (DRMD)


CO: Duramed Pharmaceuticals, Inc.; Ortho Pharmaceuticals Corp. ST: Ohio IN: MTC SU: LIC

AR-KL -- CL019 -- 9186 12/01/93 10:50 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 1, 1993
Words:154
Previous Article:LCI INTERNATIONAL WITHDRAWS OFFERING OF ADDITIONAL COMMON STOCK
Next Article:BANKUNITED FINANCIAL DECLARES REGULAR QUARTERLY CASH DIVIDENDS ON CLASS A COMMON & PREFERRED STOCK
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters